Ayuob Aghanejad

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Molecules (Basel, Switzerland)

Nanomedicine (London, England)

Journal of microencapsulation

Journal of drug targeting

Tabriz University of Medical Sciences

Tehran University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tabriz University of Medical Sciences

Iran

Assistant professor

Education History

Tehran University of Medical Sciences

Iran

PHD :: Nuclear Pharmacy

Publications

Mitra Torabi, Ayuob Aghanejad, Pouria Savadi, Abolfazl Barzegari, Yadollah Omidi, Jaleh Barar
Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles. Molecules (Basel, Switzerland) 28 (1) (2023)
Mitra Torabi, Ayuob Aghanejad, Pouria Savadi, Abolfazl Barzegari, Yadollah Omidi, Jaleh Barar
Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles. Molecules (Basel, Switzerland) 28 (1) (2023)
Mitra Torabi, Ayuob Aghanejad, Pouria Savadi, Abolfazl Barzegari, Yadollah Omidi, Jaleh Barar
Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles. Molecules (Basel, Switzerland) 28 (1) (2023)
Paniz Siminzar, Mohammad Reza Tohidkia, Elisabeth Eppard, Nasim Vahidfar, Ali Tarighatnia, Ayuob Aghanejad
Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment. Molecular imaging and biology (2022)
Seraj Mohaghegh, Ali Tarighatnia, Yadollah Omidi, Jaleh Barar, Ayuob Aghanejad, Khosro Adibkia
Multifunctional magnetic nanoparticles for MRI-guided co-delivery of erlotinib and L-asparaginase to ovarian cancer. Journal of microencapsulation 39 (4) (2022)
Nastaran Hashemzadeh, Mitra Dolatkhah, Ayuob Aghanejad, Mohammad Barzegar-Jalali, Yadollah Omidi, Khosro Adibkia, Morteza Mahmoudi
Folate receptor-mediated delivery of 1-MDT-loaded mesoporous silica magnetic nanoparticles to target breast cancer cells. Nanomedicine (London, England) 16 (24) (2021)
Fereydoon Abedi Gaballu, William Chi Shing Cho, Gholamreza Dehghan, Amir Zarebkohan, Behzad Baradaran, Behzad Mansoori, Soheil Abbaspour-Ravasjani, Ali Mohammadi, Nader Sheibani, Ayuob Aghanejad, Jafar Ezzati Nazhad Dolatabadi
Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy. Genes 12 (7) (2021)
Nastaran Hashemzadeh, Ayuob Aghanejad, Elaheh Dalir Abdolahinia, Mitra Dolatkhah, Mohammad Barzegar-Jalali, Yadollah Omidi, Morteza Mahmoudi, Khosro Adibkia
Targeted combined therapy in 2D and 3D cultured MCF-7 cells using metformin and erlotinib-loaded mesoporous silica magnetic nanoparticles. Journal of microencapsulation 38 (7-8) (2021)
Mitra Dolatkhah, Nastaran Hashemzadeh, Morteza Mahmoudi, Khosro Adibkia, Ayuob Aghanejad, Mohammad Barzegar-Jalali, Hossein Omidian, Yadollah Omidi
Stimuli-responsive graphene oxide and methotrexate-loaded magnetic nanoparticles for breast cancer-targeted therapy. Nanomedicine (London, England) 16 (24) (2021)
Nasim Vahidfar, Ayuob Aghanejad, Hojjat Ahmadzadehfar, Saeed Farzanehfar, Elisabeth Eppard
Theranostic Advances in Breast Cancer in Nuclear Medicine. International journal of molecular sciences 22 (9) (2021)
Paniz Siminzar, Yadollah Omidi, Asal Golchin, Ayuob Aghanejad, Morteza Mahmoudi
Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer. Journal of drug targeting 28 (1) (2019)
Shirin Khajeh, Mohammad Reza Tohidkia, Ayuob Aghanejad, Tayebeh Mehdipour, Farzaneh Fathi, Yadollah Omidi
Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells. Artificial cells, nanomedicine, and biotechnology 46 (sup2) (2018)

Ayuob Aghanejad.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ayuob Aghanejad